等待开盘 02-04 09:30:00 美东时间
-0.200
-0.16%
AptarGroup (ATR) declares $0.48/share quarterly dividend, in line with previous. Forward yield 1.54% Payable Feb. 25; for shareholders of record Feb. 4; ex-div Feb. 4. See ATR Dividend Scorecard, Yiel...
01-23 06:01
AptarGroup Inc. announces $0.48 per share quarterly dividend AptarGroup Inc. has announced a quarterly cash dividend of $0.48 per share, payable on February 25, 2026, to stockholders of record as of February 4, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generat
01-23 06:00
AptarGroup Earns CDP ‘A’ Score for Climate Change Disclosure AptarGroup Inc. has been recognized on the CDP Climate Change "A List" for the second consecutive year, according to a recent announcement. The company was acknowledged for its actions to reduce emissions, mitigate climate risks, and suppo
01-22 06:00
Aptar Digital Health, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced a partnership with ŌURA to integrate Aptar's
01-07 06:03
Aptar Group, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) Liquid Nasal Spray System is the mechanism for delivering
2025-12-18 06:15
AptarGroup acquired Sommaplast, a specialized provider of oral dosing pharma packaging solutions in Brazil for $30-$35 million.
2025-12-03 02:13
AptarGroup (ATR) on Monday said it has acquired Sommaplast, a specialized provider of oral dosing pharma packaging solutions, such as closures, droppers, dispensers and dosing cups, based in Brazil. S...
2025-12-02 06:23
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has acquired Sommaplast, a specialized provider of oral dosing pharma
2025-12-02 06:13
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
2025-11-04 10:31
Baird analyst Ghansham Panjabi maintains AptarGroup (NYSE:ATR) with a Outperform and lowers the price target from $160 to $145.
2025-11-03 20:35